Opportunities in China
Are you interested in exploring potential possibilities in China market? Here are a few leading companies from China seeking potential investment or collaboration partners: Company 1
- Industry: Medical Device
- Interest: Injection and infusion consumables, wound care consumables, orthopaedic, blood purification equipment and consumables, minimally invasive intervention consumables, Intelligent equipment
Company 2
- Industry: Therapeutics
- Interest: Drugs in liver disease or diabetes spaces, developing in Canada is preferred.
Please contact us for further information. You could also attend our China Focus@BIO Philadelphia to schedule 1-to-1 meetings with above-mentioned companies. Early bird rate is still available now.
| Register & Schedule 1-1 Meetings |
Confirmed Speakers
Katherine Andersen
Head of Healthcare Corporate Finance and East/Central Life Science
Silicon Valley Bank
Head of Healthcare Corporate Finance and East/Central Life Science
Silicon Valley Bank
Kim Nearing
Managing Director
Cedrus Group
Managing Director
Cedrus Group
Andrew Nerlinger
Bill Wood Ventures
Venture Partner
Bill Wood Ventures
Venture Partner
Daniel Chai
Turret Capital
Managing Partner
Turret Capital
Managing Partner
Mark Tang
Managing Director
Good Health Capital
Managing Director
Good Health Capital
Tim Xiao
Principal
Delos Capital
Principal
Delos Capital
Michael Song
Medimmune
Sr. Manager
Medimmune
Sr. Manager
Brad Loncar
Loncar Investment
CEO
Loncar Investment
CEO
Ping Cao
Henlius Biotech
VP business development
Henlius Biotech
VP business development
Gurkeerat Singh
Lilly Research Laboratories
VP Emerging Technology and Innovation
Lilly Research Laboratories
VP Emerging Technology and Innovation
Upcoming Preliminaries:
- April 30, Online
- June 2, Philadelphia
What you can get?
- The opportunity for media coverage and promotion on our English and Chinese platforms.
- 1-to-1 partnering opportunities with potential Chinese investors.
- Exhibition space for your company at China Focus forum with a surprise discount.
- The opportunity for a 5-day sponsored business development trip in China to meet 100+ investors and corporate executives.
Click here to get more information about preliminary schedule and featured prizes.
| Submit Application |
Cross-border Investment News
Cullgen Receives $16 Million Series A Investment to Advance Pipeline of Targeted Protein Degraders
- Series A financing led by two leading global venture capital firms – Sequoia Capital China and Highlight Capital